Page last updated: 2024-12-04

3-methylcatechol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-methylbenzene-1,2-diol: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

dihydroxytoluene : Any hydroxytoluene that has two hydroxy substituents [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

3-methylcatechol : A methylcatechol carrying a methyl substituent at position 3. It is a xenobiotic metabolite produced by some bacteria capable of degrading nitroaromatic compounds present in pesticide-contaminated soil samples. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID340
CHEMBL ID1173328
CHEBI ID18404
SCHEMBL ID67369
SCHEMBL ID10526382
MeSH IDM0098045

Synonyms (63)

Synonym
HMS1789D12
brn 0774602
nsc 66523
ai3-61047
einecs 207-672-6
CHEBI:18404 ,
catechol, 3-methyl-
pyrocatechol, 3-methyl-
nsc-66523
1,2-dihydroxy-3-methylbenzene
3-methyl-1,2-dihydroxybenzene
2,3-toluenediol
wln: qr bq c1
dihydroxytoluene
3-methylpyrocatechol
3-methyl-1,2-benzenediol
nsc66523
3-methylbenzene-1,2-diol
1,2-benzenediol, 3-methyl-
inchi=1/c7h8o2/c1-5-3-2-4-6(8)7(5)9/h2-4,8-9h,1h
C02923
3-methylcatechol
2,3-dihydroxytoluene
488-17-5
3-methyl-benzene-1,2-diol
3-methylcatechol, 98%
DB03454
1, 2-dihydroxy-3-methylbenzene
BMSE000334
2, 3-toluenediol
3-methyl-1, 2-dihydroxybenzene
3-methyl catechol
nsc 66523-d3
M0184
CHEMBL1173328 ,
AKOS000121356
A827610
2,3-dihydroxytoluene; 3-methylbenzene-1,2-diol;3-methylbenzene-1,2-diol
FT-0671610
unii-0huz4q9r8c
4-06-00-05860 (beilstein handbook reference)
0huz4q9r8c ,
FT-0612043
SCHEMBL67369
AM808211
3-methyl-1,2-dihydroxy benzene
DTXSID9060071
W-106038
SCHEMBL10526382
STR09012
2-hydroxy-3-methylphenol
AC-22587
F0001-1277
mfcd00016435
Z56347229
CS-W013531
Q15303191
(s)-3-amino-5,5-dimethylhexanoicacid
bdbm50548725
SY034740
HY-W012815
EN300-16625
PD007518

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" Three factors were investigated for the identification of an appropriate organic solvent and they included solvent toxicity, bioavailability of the solvent as well as solvent affinity for 3MC."( Solvent selection for enhanced bioproduction of 3-methylcatechol in a two-phase partitioning bioreactor.
Daugulis, AJ; Prpich, GP, 2007
)
0.6
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
bacterial xenobiotic metaboliteAny bacterial metabolite produced by metabolism of a xenobiotic compound in bacteria.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
methylcatecholAny member of the class of catechols carrying one or more methyl substituents.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (9)

PathwayProteinsCompounds
2-nitrotoluene degradation312
naphthalene degradation (aerobic)929
superpathway of aromatic compound degradation via 2-hydroxypentadienoate5095
naphthalene degradation to acetyl-CoA1138
toluene degradation I (aerobic) (via o-cresol)517
toluene degradation to 2-hydroxypentadienoate I (via o-cresol)512
toluene degradation to 2-hydroxypentadienoate (via toluene-cis-diol)513
toluene degradation V (aerobic) (via toluene-cis-diol)718
superpathway of aerobic toluene degradation3847

Protein Targets (1)

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Transient receptor potential cation channel subfamily A member 1Homo sapiens (human)EC50 (µMol)2.83000.00033.166210.0000AID1682372
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (17)

Processvia Protein(s)Taxonomy
monoatomic ion transportTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
intracellular calcium ion homeostasisTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cell surface receptor signaling pathwayTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to coldTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to xenobiotic stimulusTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to organic substanceTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to organic cyclic compoundTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
calcium-mediated signalingTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
thermoceptionTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
detection of mechanical stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
detection of chemical stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
protein homotetramerizationTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cellular response to hydrogen peroxideTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
calcium ion transmembrane transportTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cellular response to organic substanceTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (5)

Processvia Protein(s)Taxonomy
calcium channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
intracellularly gated calcium channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
identical protein bindingTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
temperature-gated cation channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (2)

Processvia Protein(s)Taxonomy
plasma membraneTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
stereocilium bundleTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (8)

Assay IDTitleYearJournalArticle
AID1335036Cytotoxicity against human TK10 cells assessed as cell growth inhibition after 48 hrs by SRB assay2017Bioorganic & medicinal chemistry, 02-01, Volume: 25, Issue:3
A one-pot laccase-catalysed synthesis of coumestan derivatives and their anticancer activity.
AID492140Antioxidant activity assessed as formazan formation induced absorbance changes at 25 ppm at 570 nm at 37 degC for 6 hrs by MTT assay2010Journal of natural products, Jul-23, Volume: 73, Issue:7
An efficient and economical MTT assay for determining the antioxidant activity of plant natural product extracts and pure compounds.
AID1335037Cytotoxicity against human UACC62 cells assessed as cell growth inhibition after 48 hrs by SRB assay2017Bioorganic & medicinal chemistry, 02-01, Volume: 25, Issue:3
A one-pot laccase-catalysed synthesis of coumestan derivatives and their anticancer activity.
AID1335038Cytotoxicity against human MCF7 cells assessed as cell growth inhibition after 48 hrs by SRB assay2017Bioorganic & medicinal chemistry, 02-01, Volume: 25, Issue:3
A one-pot laccase-catalysed synthesis of coumestan derivatives and their anticancer activity.
AID1682372Agonist activity at TRPA1 (unknown origin) by calcium imaging assay2021Bioorganic & medicinal chemistry letters, 01-01, Volume: 31Discovery of natural TRPA1 activators through pharmacophore-based virtual screening and a biological assay.
AID1682371Agonist activity at TRPA1 (unknown origin) by calcium imaging assay relative to allyl isothiocyanate2021Bioorganic & medicinal chemistry letters, 01-01, Volume: 31Discovery of natural TRPA1 activators through pharmacophore-based virtual screening and a biological assay.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (40)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (5.00)18.7374
1990's8 (20.00)18.2507
2000's13 (32.50)29.6817
2010's14 (35.00)24.3611
2020's3 (7.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 29.34

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index29.34 (24.57)
Research Supply Index3.71 (2.92)
Research Growth Index5.04 (4.65)
Search Engine Demand Index36.02 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (29.34)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other40 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]